Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Clinical trials referral resource. Clinical trials in lung cancer.

Feigal EG, Cheson BD, Nelson AP.

Oncology (Williston Park). 1997 Nov;11(11):1686, 1688, 1691, 1694. No abstract available.

PMID:
9394366
2.

Lung cancer.

Giaccone G, Smit EF.

Cancer Chemother Biol Response Modif. 2001;19:485-534. Review. No abstract available.

PMID:
11686030
3.

[What is to be expected from population studies in relation to clinical trials?].

Quoix E.

Rev Pneumol Clin. 2006 Feb;62 Spec no 1:1S19-21. French. No abstract available.

PMID:
16719151
4.

Combined modality treatment of lung cancer (NSCLC and SCLC).

Delbaldo C, Le PĂ©choux C, Le Chevalier T.

Cancer Chemother Biol Response Modif. 2002;20:677-95. Review. No abstract available.

PMID:
12703230
5.

Targeted therapy for lung cancer.

Kukunoor R, Shah J, Mekhail T.

Curr Oncol Rep. 2003 Jul;5(4):326-33. Review.

PMID:
12781076
6.

[Recommendations on the therapy of bronchial carcinoma].

Thomas M, Baumann M, Deppermann M, Freitag L, Gatzemeier U, Huber R, Passlick B, Serke M, Ukena D.

Pneumologie. 2002 Feb;56(2):113-31. Review. German. No abstract available.

PMID:
11842350
7.

Systemic and combined modality therapy for lung cancer.

Ettinger DS.

Md Med J. 1990 Apr;39(4):315-6. No abstract available.

PMID:
2159100
8.

Lung cancer treatment present and future.

Cho JK.

Hawaii Med J. 2003 Mar;62(3):61-2. No abstract available.

PMID:
12703177
9.

[Cancer of the lung. New perspectives in medical treatment].

Gallo Curcio C.

Arch Monaldi Mal Torace. 1989 Jul-Dec;44(4-6):781-90. Italian. No abstract available.

PMID:
2577795
10.

Medical treatment of lung cancer.

Kelly K, Mikhaeel-Kamel N.

J Thorac Imaging. 1999 Oct;14(4):257-65. Review.

PMID:
10524806
11.

Therapy of limited stage small cell lung cancer.

Curran WJ Jr.

Cancer Treat Res. 2001;105:229-52. Review. No abstract available.

PMID:
11224989
12.

Summary of the proceedings of the United States-Japan lung cancer clinical trials summit. Maui, Hawaii, 24-25 February 1996.

Livingston RB, Tsuchiya R, Fukushima M, Coltman CA Jr.

J Cancer Res Clin Oncol. 1997;123(8):461-6. No abstract available.

PMID:
9292711
13.

Combined modality therapy of non-small cell lung cancer.

Ruckdeschel JC.

Semin Oncol. 1997 Aug;24(4):429-39. Review.

PMID:
9280223
14.

Lung cancer: review of the ECOG experience. Eastern Cooperative Oncology Group.

Schiller JH, Cleary J, Johnson D.

Oncology. 1997 Sep-Oct;54(5):353-62. Review.

PMID:
9260595
15.

[Management of non-small-cell lung carcinoma (NSCLC) of stage III B].

Koukourakis M.

Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S33-6. Review. French. No abstract available.

PMID:
11924241
16.
17.

Ongoing clinical trials in lung cancer.

Giaccone G, Tonato M.

Eur J Surg Oncol. 1996 Feb;22(1):4-9. Review. No abstract available.

PMID:
8846865
18.

Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998.

Leigh BR, Gandara DR, Crowley JJ, Furuse K, Livingston RB, Fukushima M, Coltman CA Jr.

Lung Cancer. 1999 Jun;24(3):181-91. No abstract available.

PMID:
10460006
19.

[Combined modality treatment of lung cancer: present and future].

Ohta M, Hara N.

Nihon Kyobu Shikkan Gakkai Zasshi. 1986 Nov;24(11):1186-91. Review. Japanese. No abstract available.

PMID:
3031350
20.

[Recent progress and perspectives in the management of patients with lung cancer].

Barlesi F, Gimenez C, Pibarot M, Kleisbauer JP.

Bull Cancer. 2002 Jan;89(1):57-66. Review. French.

Items per page

Supplemental Content

Support Center